To access all features of this site, you must enable Javascript. Here are the instructions for enabling Javascript in your web browser.
To carry out their activities, Research Teams of the Frédéric Joliot Institute for Life Sciences have developed high-profile technological platforms in many areas : biomedical imaging, structural biology, metabolomics, High-Throughput screening, level 3 microbiological safety laboratory...
Within the Institute, the "Funding Research and Technology Transfer" team is at your disposal to identify the scientists and the skills you need to set up a joint project, to define the terms of a collaboration contract or study. Whether you are an academic, a SME or an industrialist, our team informs and advices you about the possibilities of consortium assembly, technology transfer, patent licensing or use of our platforms. The team is also at the disposal of the researchers of the institute to accompany them in achieving their valorization objectives.
All the news of the Institute of life sciences Frédéric Joliot
As part of the InFoR-Autism scientific program involving NeuroSpin, a new neuroimaging study has revealed a correlation between decreased local anatomical connectivity and social cognitive deficits in people with autism spectrum disorders (ASD). Published in the renowned journal Brain, the results challenge the dominant theoretical model explaining ASD and could pave the way for the exploration of new therapeutic approaches.
The goal of the PRIME-DE data exchange is to make primate brain imaging datasets acquired in laboratories available to the entire scientific community. PRIME-DE was created by an international consortium of 22 teams including one from NeuroSpin, all working with macaques. The PRIME-DE initiative, presented in an article published in Neuron should enhance the statistical relevance of acquired data and limit the number of animals used in research.
A research team from the SB2SM (I2BC@Saclay), in collaboration with the CNRS, SOLEIL , Universities of Paris-Sud, Aix-Marseille and Paul Sabatier - Toulouse III and Gustave Roussy, has resolved structures of two complexes involved in radiation-induced DNA damages. These results were published in Nature Structural & Molecular Biology on October, the 5th.
A SHFJ research team (LDM-TEP, GIP Cyceron, Caen) has previously developed and produced a radiopharmaceutical, the [18F]-Fludarabine, to detect lymphomas using PET scan. The team has recently conducted a preclinical study that shows the molecule can help in diagnosis of cerebral lymphoma by differentiate it from glioblastoma, the main brain tumor. A clinical study should be launched before the end of the year.
Directed by Thierry Meinnel, it carries out research on Integrative Biology of the Cell.
Directed by Christophe Junot, it carries out research on Molecular Innovation for human health.
Directed by Stanislas Dehaene, it is a Research Infrastructure designed to study the singularity of the brain.
Directed by Vincent Lebon, it carries out research in Molecular and Functional Imaging and provides a medical service mission.
Conference | CEA Paris-Saclay, site de Fontenay-aux-Roses, IDMIT, Bâtiment 62, Salle Dormont
Grasse
The 4th European Workshop of sub-units NF-kB will be held from 8 - 10 October 2018 in Grasse.
Event | Fontenay aux Roses
The 12th International Conference on Health Effects after Radionuclide Incorporation is organized from 8 to 11 October 2018 in Fontenay-Aux-Roses.
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.